MetaCap

Aurora Cannabis (ACB) vs Cronos Group (CRON)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Cronos Group (CRON) has outperformed Aurora Cannabis (ACB) over the past year, gaining 28.3% versus a loss of 1.2%. Over five years, CRON leads with a -34.9% price change compared with -93.9% for ACB. Cronos Group is the larger company by market cap ($1.11 billion vs $273.5 million), about 4.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ACB-1.19%CRON+28.27%
+62%+9%-44%
Nov 21, 20251 yearNov 20, 2026
ACB-94.09%CRON-38.34%
+5%-48%-101%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ACB versus CRON key metrics
MetricACBCRON
Share price$4.16$3.04
Market cap$273.50M$1.11B
1-day change-2.35%-1.30%
YTD return-1.42%+15.59%
1-year return-1.19%+28.27%
5-year return-93.87%-34.90%
P/E ratio (TTM)—19.00
EPS (TTM)$-0.19$0.16
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$146.59M
Revenue growth (YoY)—+24.63%
Net income (latest FY)—$-9.45M
Gross margin—42.81%
Operating margin—-11.87%
Net margin—-6.44%
52-week high$6.36$3.91
52-week low$2.56$2.35
Distance from 52-week high-34.59%-22.25%
Analyst consensusunderperformstrong_buy
Avg. price target upside—-3.62%
Average volume1.31M1.07M
Shares outstanding65.74M366.47M
Employees1,028610
SectorHealth CareHealth Care
Industry Medicinal Chemicals and Botanical Products Medicinal Chemicals and Botanical Products

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Cronos Group is about 4.1 times larger than Aurora Cannabis by market value ($1.11B vs $273.50M).
  • CRON has outperformed ACB by 29.5 percentage points over the past year.

About Aurora Cannabis

ACB stock →

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products.

Health Care · Medicinal Chemicals and Botanical Products · 1,028 employees

About Cronos Group

CRON stock →

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names.

Health Care · Medicinal Chemicals and Botanical Products · 610 employees

ACB vs CRON FAQ

Which is bigger, Aurora Cannabis or Cronos Group?

Cronos Group (CRON) is larger, with a market capitalization of $1.11B compared with $273.50M for Aurora Cannabis (ACB).

Which stock has performed better over the past year, ACB or CRON?

CRON returned +28.27% over the past 12 months, compared with -1.19% for ACB (price return, excluding dividends). Past performance does not predict future results.

Are Aurora Cannabis and Cronos Group in the same industry?

Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.

More comparisons